Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3
PaperCitations, authors & open-access status
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 234 citations, 2017 year and gold oa status.
234
Citations
2017
Year
gold
OA Status